Sarepta Therapeutics, Inc. (SRPT) Holders & Ownership

Sarepta Therapeutics, Inc. (SRPT) ownership: Entities Affiliated with AQR Capital Management 15% · institutions 90% · index and ETF funds 10% (13F 2026-03-31). Insider activity, 90 days: 0 sales, 0 open-market buys. 7 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.

Top Institutional Holders (13F, rolled up by parent)

Source: SEC Form 13F
HolderSharesMarket Value% OutstandingReported
BlackRock14755277.00$321.07M14.0%2026-03-31
Vanguard12120284.00$263.74M11.5%2026-03-31
State Street6613314.00$143.91M6.3%2026-03-31
AQR Capital Management6433112.00$138.63M6.1%2026-03-31
Two Sigma4593195.00$99.95M4.4%2026-03-31
First Trust Advisors LP4135788.00$89.99M3.9%2026-03-31
RA Capital Management, L.P.3902596.00$84.92M3.7%2026-03-31
Norges Bank1192398.00$76.10M1.1%2026-03-31

Insider Trading Activity (Form 4)

Source: SEC Form 4
InsiderTransactionValueDate
Sellnull2026-07-28
Sellnull2026-07-28
Sellnull2026-03-12
Buynull2026-03-11
Buynull2026-03-11
Buynull2026-03-11
Buynull2026-03-11
Buynull2026-03-09

Back to SRPT overview · SRPT earnings · All congressional trades

Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.